ANTENGENE-B (06996) has issued a total of 1.9 million share options and 250,000 restricted share units.

20:13 07/04/2026

Deck Pharmaceuticals-B (06996) announced that on April 2, 2026, the company granted a total of 1.9 million share options to five grantees under the 2020 equity incentive plan. Additionally, the company granted 250,000 restricted share units to four of the grantees under the 2022 restricted share unit plan. However, the grants will only become effective once the grantees accept and comply with the listing rules, as well as the respective terms of the 2020 equity incentive plan and the 2022 restricted share unit plan.

ANTENGENE-B (06996) announces that on April 2, 2026, the company granted a total of 1.9 million share options to five grantees under the 2020 equity incentive plan, and granted 250,000 restricted share units to four of them under the 2022 restricted share unit plan. However, the grantee must accept and comply with the listing rules, as well as the terms of the 2020 equity incentive plan and the 2022 restricted share unit plan, before the grant can be effective.

US Stock Market Move | Tesla, Inc. (TSLA.US) drops nearly 4% as JP Morgan sharply sells shares, warning of a possible 60% crash.

US Stock Market Move | Broadcom Inc. (AVGO.US) opened up nearly 4%, will supply TPU chips for Alphabet Inc. Class C, and provide computing power for Anthropic.

US Stock Market Move | Health insurance companies collectively traded higher, with Humana (HUM.US) rising over 9%.

US Stock Market Move | Tesla, Inc. (TSLA.US) drops nearly 4% as JP Morgan sharply sells shares, warning of a possible 60% crash.

US Stock Market Move | Broadcom Inc. (AVGO.US) opened up nearly 4%, will supply TPU chips for Alphabet Inc. Class C, and provide computing power for Anthropic.

US Stock Market Move | Health insurance companies collectively traded higher, with Humana (HUM.US) rising over 9%.